Automation

Scientific progress in cell and gene therapies is accelerating, but global manufacturing capacity is struggling to keep pace. We're committed to building and providing advanced automation capabilities and infrastructure to enable partners to evaluate and implement automation solutions, scale high-quality ATMP manufacturing processes and meet real-world patient needs.

Whether you're a therapy developer, enabling technology provider, regulator, or investor, we can support you.

Technical de-risking and integration 

Our team of experts can support you in overcoming critical R&D barriers by providing tailored guidance and purpose-built environments to de-risk your therapeutic and technical innovations at R&D scale. 

We can help ensure smooth and compliant integration into scalable manufacturing processes, accelerating your path from development to deployment.

Benefit from:

  • End-to-end support across the full lifecycle, from strategic planning and technology mapping to full-scale deployment
  • Expertise in validating and integrating novel technologies for cell and gene therapy development
  • Early identification and mitigation of potential risks during technology validation and process integration
  • Access to a unique cross-industry collaborator ecosystem
  • Accelerated market readiness and adoption timelines through innovative testing with high-value outputs, ranging from learnings to blueprints and frameworks to be adopted

Robotics and automation 

Our Digital and Automation Testbeds offer a real-world, GMP-mirroring environment within an MHRA-licensed facility, purpose-built to help innovators de-risk the development, testing, and adoption of next-generation manufacturing technologies and processes.

Whether you’re validating new automation platforms, digital tools, or advanced analytics, our Testbeds provide the infrastructure, regulatory alignment, and expert support needed to accelerate integration into real-world CGT manufacturing.

Benefit from:

  • Strategic automation assessment through our Automation Strategy Roadmap, identifying high-impact opportunities to inform scalable, future-ready manufacturing strategies
  • State-of-the-art robotic and automation technologies designed to meet the evolving needs of advanced therapy manufacturing
  • On-site infrastructure and multidisciplinary expertise to support any cell and gene therapy modality or enabling technology from concept through to implementation

Advanced analytics

Unlock the full potential of your advanced therapy development with streamlined, data-driven decision making. Our team can support you to enhance your analytical capabilities by reducing complexity, increasing speed and improving confidence across your process.

Benefit from our expertise in:

  • Implementing condensed analytics that reduce complexity and deliver actionable insights in real-time
  • Overcoming quality control (QC) bottlenecks, enhancing throughput and ensuring timely analysis
  • Enabling real-time release testing for rapid product quality verification and accelerated time to market
  • Providing scalable, compliant analytical solutions aligned with regulatory standards and optimised for operational efficiency

News feed

Working on a cell or gene therapy innovation challenge?

Contact us today to find out how we can support you.